Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Tag: NICE


Dapagliflozin with insulin for treating type 1 diabetes

February 18th 2020

Technology appraisal guidance [TA597] Published date: 28 August 2019 Last updated: 12 February 2020 (NICE)

Categories: Guidelines, News
Tags: dapagliflozin, NICE

Categories: Guidelines
Tags: dapagliflozin, NICE

New – Hypertension in adults: diagnosis and management added to T2D guidelines

September 3rd 2019

This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively (NICE)

Categories: Hypertension, News
Tags: NICE

Categories: Hypertension
Tags: NICE

Dapagliflozin with insulin for treating type 1 diabetes

September 3rd 2019

Evidence-based recommendations on dapagliflozin (Forxiga) with insulin for treating type 1 diabetes not controlled by insulin therapy alone in adults with a body mass index (BMI) of at least 27 kg/m2 (NICE)

Categories: Medication, News
Tags: dapagliflozin, Forxiga, NICE, Type 1 Diabetes

Categories: Medication
Tags: dapagliflozin, Forxiga, NICE, Type 1 Diabetes

Dapagliflozin with insulin for treating type 1 diabetes

July 15th 2019

Recommendations (NICE)

Categories: Medication, News
Tags: dapagliflozin, NICE, Type 1 Diabetes

Categories: Medication
Tags: dapagliflozin, NICE, Type 1 Diabetes

Surveillance proposal consultation document

April 25th 2019

2019 surveillance of 4 diabetes guidelines (NICE)

Categories: Audits, News
Tags: NICE

Categories: Audits
Tags: NICE

Type 2 diabetes mellitus: medicines optimisation priorities

March 27th 2019

This document summarises the evidence base on type 2 diabetes mellitus: medicines optimisation priorities. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance

Categories: Medication, News
Tags: NICE, Type 2 Diabetes

Categories: Medication
Tags: NICE, Type 2 Diabetes

Medical devices: information for users and patients

February 11th 2019

Including blood glucose meters (NICE)

Categories: Monitoring, News
Tags: meters, NICE

Categories: Monitoring
Tags: meters, NICE

Managing hypertension in people of African origin with diabetes: Evaluation of adherence to NICE Guidelines

January 29th 2019

This study provides insight into adherence to NICE guidance for managing hypertension in African origin patients with diabetes. Further work should be done to explore the effects of hypertension in this ethnic group and if there is a need for a more refined management guideline (Primary Care Diabetes)

Categories: Hypertension, News
Tags: African, NICE

Categories: Hypertension
Tags: African, NICE

NICE impact diabetes

September 26th 2018

This report considers how NICE’s evidence-based guidance can contribute to improvements in the prevention and management of diabetes

Categories: Management, News
Tags: NICE

Categories: Management
Tags: NICE

Type 2 diabetes: prevention in people at high risk

September 15th 2017

This guideline covers how to identify adults at high risk of type 2 diabetes. It aims to remind practitioners that age is no barrier to being at high risk of, or developing, the condition (NICE)

Categories: News, Prevention
Tags: NICE, Type 2 Diabetes

Categories: Prevention
Tags: NICE, Type 2 Diabetes

Obese, overweight with risk factors: liraglutide (Saxenda)

June 27th 2017

This evidence summary discusses 4 randomised controlled trials (RCTs) in adults who were obese or overweight (BMI 27 kg/m2 or above) with a variety of weight-related comorbidities including dyslipidaemia, hypertension, type 2 diabetes and obstructive sleep apnoea (NICE)

Categories: News, Obesity
Tags: liraglutide, NICE

Categories: Obesity
Tags: liraglutide, NICE

Type 2 diabetes prevention. Standing committee C update

May 24th 2017

Addendum consultation (NICE)

Categories: News, Prevention
Tags: NICE, Type 2 Diabetes

Categories: Prevention
Tags: NICE, Type 2 Diabetes

Type 2 diabetes in adults: management

May 9th 2017

This updated guideline covers the care and management of type 2 diabetes in adults (aged 18 and over). It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications (NICE)

Categories: Management, News
Tags: NICE

Categories: Management
Tags: NICE

Neuropathic pain in adults: pharmacological management in non-specialist settings

February 23rd 2017

This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic neuropathy by reducing pain and promoting increased participation in all aspects of daily living (NICE)

Categories: Neuropathy, News
Tags: NICE, pharmacological

Categories: Neuropathy
Tags: NICE, pharmacological

Dapagliflozin in triple therapy for treating type 2 diabetes

November 24th 2016

Evidence-based recommendations on dapagliflozin (Forxiga) given with 2 other drugs for treating type 2 diabetes in adults (NICE)

Categories: Medication, News
Tags: dapagliflozin, Forxiga, NICE, Type 2 Diabetes

Categories: Medication
Tags: dapagliflozin, Forxiga, NICE, Type 2 Diabetes

Diabetes (type 1 and type 2) in children and young people: diagnosis and management

November 8th 2016

This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends strict targets for blood glucose control to reduce the long-term risks associated with diabetes (NICE)

Categories: News, Paediatrics
Tags: NICE, Type 1 Diabetes, Type 2 Diabetes

Categories: Paediatrics
Tags: NICE, Type 1 Diabetes, Type 2 Diabetes

UrgoStart for chronic wounds

October 5th 2016

The technology described in this briefing is the UrgoStart wound dressing. It is used to treat chronic wounds such as diabetic foot ulcers, pressure ulcers or venous leg ulcers, as well as non-healing acute wounds (NICE)

Categories: News, Wound Care
Tags: NICE, UrgoStart

Categories: Wound Care
Tags: NICE, UrgoStart

Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales

September 22nd 2016

In over three-quarters of patients, anti-diabetic drugs are being prescribed per NICE guidance. When insulin is being used earlier than recommended, there appears to be a need for urgent and rapid glycaemic control  (Pharmacoepidemiology and Drug Safety)

Categories: Medication, News
Tags: NICE, Type 2 Diabetes

Categories: Medication
Tags: NICE, Type 2 Diabetes

Type 1 diabetes in adults: diagnosis and management

July 15th 2016

This guideline covers the care and treatment of adults (aged 18 and over) with type 1 diabetes (NICE)

Categories: Guidance, News
Tags: NICE, Type 1 Diabetes

Categories: Guidance
Tags: NICE, Type 1 Diabetes

Type 2 diabetes in adults: management

July 15th 2016

This guideline covers the care and management of type 2 diabetes in adults (aged 18 and over). It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications (NICE)

Categories: Guidance, News
Tags: NICE, Type 2 Diabetes

Categories: Guidance
Tags: NICE, Type 2 Diabetes
  • 1
  • 2
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsors

Boehringer Ingelheim Lilly

Gold Sponsors

Sanofi DiabetesNapp DiabetesNovo NordiskAstraZeneca

Silver Sponsors

Abbott Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)AmgenAbout Ascensia Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 Empagliflozin exenatide GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis lada liraglutide metformin microvascular mortality NAFLD NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes USA Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2021 Glycosmedia Partnership